Trial to Evaluate a Modified Vaccine (Triplex ) in Adults with HIV-1 and CMV Who Are on Potent Combination ART with Conserved Immune Function

Recruiting
18 years - 99 years
All
Phase 2
90 participants needed
1 Location

Brief description of study

The purpose of this study is to see if an investigational vaccine for cytomegalovirus (CMV), called Triplex®, is safe when given to people with both Human Immunodeficiency Virus (HIV) and CMV.

Detailed description of study

The purpose of this study is to see if an investigational vaccine for cytomegalovirus (CMV), called Triplex®, is safe when given to people with both Human Immunodeficiency Virus (HIV) and CMV.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: HIV
  • Age: 18 years - 99 years
  • Gender: All

Adults with both HIV and CMV, taking anti-HIV drugs that have controlled the amount of HIV in the blood

Updated on 04 Aug 2024. Study ID: 850446

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center